Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background

technical paper

ENDO 2020

Virtual, United States

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Please log in to leave a comment

Next from ENDO 2020

Innovations in Treatments: Device- and Drug-Based Approaches for Management of T1D
technical paper

Innovations in Treatments: Device- and Drug-Based Approaches for Management of T1D

ENDO 2020

Lori  Laffel
Lori Laffel

10 June 2020

Similar lecture

Introduction to Novel Neuropeptides in Reproductive Axis Regulation
technical paper

Introduction to Novel Neuropeptides in Reproductive Axis Regulation

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved